Expectations trend
FY2028 · fiscal year ending 2028-11-01 · fmp
$17.53 → $17.53 · observed estimates
Ciena (CIEN)
NYSEInformation TechnologyCommunication EquipmentSnapshot 2026-11-04
$230.81-15.22%
Close 2026-11-05 · 1-day change
NYSEInformation TechnologyCommunication EquipmentSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for CIEN yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Multi-year backlog supports revenue growth | The backlog supports multi-year growth. | Intact | Backlog shrinks significantly or fails to support growth | Backlog $10B target vs multi-year runway BofA sets $10B backlog target; Ciena targets $14B 2029 revenue as optical demand outruns supply. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-11-01 · fmp
$17.53 → $17.53 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Dec 10, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
CIEN is a growth company whose multi-year view depends on sustaining strong revenue growth and turning that growth into better operating margins. The thesis is intact, though momentum has weakened recently and overall risk is high.
CIEN trades at a sizable premium to peers, which the evidence links to expectations of durable growth. The valuation is marked expensive, and the expectations gap is negative, suggesting results may need to stay strong to support that premium; confidence in this assessment is low.
Near term, fiscal 2026 revenue guidance has risen consistently, and recent revenue and gross margin results have improved. Operating margin has also improved, though progress against the stated goal is mixed; earnings surprises have been trending down, with a deep miss in the recent history.
The multi-year thesis hinges on CIEN sustaining growth and margins without reversing its raised guidance, since a guidance cut could also damage management credibility. Near-term sector conditions matter too: easier Fed policy or steadier results from sector peers could help the backdrop, while the evidence does not establish that either will occur.
Over the next 1 to 3 years, CIEN’s business case rests on continued execution, while its premium valuation and high risk make any loss of momentum important. The thesis is intact, but recent momentum has weakened. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Gross margin is expected near 43% next quarter. |
| Intact |
| Gross margin falls below 40% in FY26 |
Gross margin: 45.43% FY2026-Q3; GAAP. Published target: ~43%. Annual target cannot be compared with a quarterly or TTM observation. Sep 3, 202645.434254 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Operating margin reaches about 17% in fiscal 2026 | The company raised revenue guidance to about $6.3 billion for fiscal 2026. | Intact | Operating margin stays below 13% in FY26 | Operating margin: 18.02% FY2026-Q3; GAAP. Published target: ~17%. Annual target cannot be compared with a quarterly or TTM observation. Sep 3, 202618.022487 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows to about $6.3 billion in fiscal 2026 | The company raised revenue guidance to about $6.3 billion for fiscal 2026. | Intact | Revenue falls below $5.9 billion in FY26 | Revenue: $1.671B FY2026-Q3; GAAP. Published target: ~$6.3 billion. Annual target cannot be compared with a quarterly or TTM observation. Sep 3, 20261,671,129,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$10.95B → $10.95B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-11-02 | $17.53 | $10,950,220,029 | 6 / 16 |
| 2026-11-03 | $17.53 | $10,950,222,936 | 6 / 16 |
| 2026-11-04 | $17.53 | $10,950,222,936 | 6 / 16 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 17 Buy / Strong Buy · 5 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.